bluebird bio extends selloff as BofA and J.P. Morgan cut after Q3 results
(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...
The extraordinary life of JP Morgan’s librarian Belle da Costa Greene
A New York exhibition pays homage to a Black woman who passed as white and assembled the financier’s private collection ...